FDA NDC Directory · JSON-LD · Markdown

IBANDRONATE SODIUM

NDC 69452-378 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerBionpharma Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA078998
Dosage form / routeTABLET · ORAL
Active ingredientsIBANDRONATE SODIUM (150 mg/1)
Marketing started20230526
Package count1

External sources

Source: openFDA. Public-domain (CC0).